Skip to main content
. 2018 Feb 21;28:7. doi: 10.1038/s41533-018-0074-x

Table 2.

Unadjusted and adjusted associations between aspirin use and severity of acute exacerbation of chronic obstructive pulmonary disease

Outcomes Aspirin users Non-users Unadjusted association (95% CI) P-value Adjusted association (95% CI) P-value
Main analysis
 In-hospital deatha 1.0% (0.8–1.1%) 1.4% (1.4–1.5%) 0.67 (0.56–0.80) <0.001 0.60 (0.50–0.72) <0.001
 Invasive mechanical ventilationa 1.7% (1.5–1.9%) 2.6% (2.5–2.6%) 0.64 (0.56–0.74) <0.001 0.64 (0.55–0.73) <0.001
 NIPPV usea 7.6% (7.2–8.1%) 7.2% (7.1–7.3%) 1.06 (0.99–1.13) 0.06 1.05 (0.98–1.12) 0.20
 Hospital LOS, days, median (IQR)b 3 (2–5) 4 (2–6) −6% (−4 to −7%) <0.001 −7% (−5 to −9%) <0.001
Sensitivity analysis 1c
 In-hospital deatha 1.0% (0.8–1.3%) 1.3% (1.1–1.3%) 0.85 (0.67–1.09) 0.20 0.72 (0.56–0.93) 0.01
 Invasive mechanical ventilationa 1.8% (1.5–2.1%) 2.4% (2.3–2.5%) 0.74 (0.61–0.89) 0.002 0.71 (0.59–0.87) 0.001
 NIPPV usea 8.0% (7.3–8.7%) 7.1% (7.0–7.2%) 1.15 (1.05–1.27) 0.002 1.10 (0.99–1.21) 0.053
 Hospital LOS, days, median (IQR)b 3 (2–5) 3 (2–5) −2% (0 to −5%) 0.10 −5% (−2 to −8%) <0.001
Sensitivity analysis 2d
 In-hospital deatha 0.8% (0.6–1.1%) 1.0% (1.0–1.1%) 0.81 (0.59–1.11) 0.19 0.66 (0.47–0.92) 0.02
 Invasive mechanical ventilationa 1.8% (1.5–2.2%) 2.4% (2.3–2.5%) 0.79 (0.64–0.97) 0.02 0.77 (0.62–0.95) 0.02
 NIPPV usea 7.2% (6.5–7.9%) 6.2% (6.1–6.4%) 1.20 (1.08–1.34) 0.001 1.15 (1.03–1.29) 0.02
 Hospital LOS, days, median (IQR)b 3 (2–5) 3 (2–5) −1% (−4 to −2%) 0.52 −4% (−7 to −1%) 0.02

CI confidence interval, NIPPV non-invasive positive pressure ventilation, IQR interquartile range

aOdds ratio of aspirin use for each outcome in comparison with non-aspirin use, by using logistic regression model with generalized estimating equation to account for patient clustering within hospitals

bPercent change in hospital LOS, by using negative binomial model with generalized estimating equation to account for patient clustering within hospitals

cAmong patients without coronary artery diseases or ischemic stroke, 6753 patients were aspirin users and 136,325 patients were non-users

dAmong patients without coronary artery diseases, ischemic stroke, or heart failure, 5257 patients were aspirin users and 114,425 patients were non-users